According to a new report from Global Market Insights, the U.S. cannabis testing market is projected to reach $1.2 billion by 2026. The report showed the growth of the testing industry will occur with rigorous government regulations and increased investment into the research of medical marijuana, which remains largely unexplored due to cannabis’s federally illegal status. Cannabis testing, although standards vary from state to state, includes testing products for heavy metals, pesticides, and residual solvents, as well as testing the THC or CBD potency. Divided by testing technology, the cannabis testing market in the U.S. consists of several smaller markets like chromatography and spectroscopy. The report highlights the chromatography market will show a CAGR (compound annual growth rate) of 10.4% by 2026.

Jelena Cikes, Greencamp, 08/27/2020 14:05:54

Open article: